Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Psilocybin in Post-Treatment Lyme Disease

NCT05305105 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT05305105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05305105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Psilocybin in Post-Treatment Lyme Disease
Lead sponsor
Johns Hopkins University
Phase
Phase 1
Overall status
Completed
Start date
July 1, 2022
Completion date
April 7, 2025
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lyme disease, lyme disease, chronic, post-treatment lyme disease